Skip to content

CVS Health CVS Q3 2024 earnings

Reported November 6, 2024 · Before market open

Revenue estimate$92.7B
EPS estimate$1.44

Next report

Jul 30, 2026 (in a month)
Revenue estimate$100.17B
EPS estimate$1.86

Financials

Q3 2024

Income statement

See full
Revenue$95.4B+6.3%
Gross profit$42.5B+21.1%
Operating income$832.0M-77.5%
Net income$87.0M-96.2%
EPS (diluted)$0.07-96.0%

Balance sheet

See full
Cash & equivalents$7.1B-46.6%
Total debt$84.9B+4.0%
Total equity$74.9B+0.8%
Total assets$252.43B+0.4%

Cash flow

See full
Operating cash flow--100%
CapEx$670.0M+22.9%

Valuation & ratios

Q3 2024

Valuation

See full
Market cap$79.1B-11.8%
Enterprise value$156.84B-0.7%
P/E15.8×+5.4×
P/S0.2×0.0×

Profitability

See full
Gross margin43.5%+4.3pp
Operating margin2.6%-1.5pp
Net margin1.4%-1.1pp

Returns & leverage

See full
Return on equity6.7%-5.2pp
Debt / equity1.1×0.0×
Current ratio0.8×-0.1×

Segments

By segment

See full
Health Services$44.1B-5.9%
Health Care Benefits$33.0B+25.5%
Pharmacy & Consumer Wellness$32.4B+12.3%
Corporate Other$142.0M

Versus estimates

Ask the moment CVS Health reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did CVS Health report Q3 2024 earnings?
CVS Health (CVS) reported Q3 2024 earnings on November 6, 2024 before market open.
What were CVS Health's Q3 2024 revenue and EPS?
CVS Health reported revenue of $95.4B and diluted EPS of $1.09 for Q3 2024.
Did CVS Health beat estimates in Q3 2024?
Revenue beat the consensus estimate of $92.7B by $2.7B. EPS missed the consensus estimate of $1.44 by $0.35.
Where can I find CVS Health's Q3 2024 SEC filings?
You can read the 10-Q periodic report (0000064803-24-000034) directly on SEC EDGAR. The filing index links above go to sec.gov.